Ch 47: Gout Flashcards
normal serum urate level
2.0-7.2 mg/dl
risk factors
male, obesity, excessive etoh, HTN, CKD, lead intox, adv age, meds that inc urate
asx hyperuricemia tx
none
acute gout attack tx
monotx with NSAID, sys steroid (or intra-articular), or PO colchicine. if severe: combo tx. ice can help. if on ULT, do not interrupt tx during flare.
common gout location
metatarsophalangeal joint (MTP) aka big toe
tophi
uric acid crystals that form under the skin in long-term gout
chronic ULT
use NSAIDs or colchicine for ppx to reduce risk of gout flare when initiating ULT. 1st line ULT is allopurinol or febuxostat, titrated up to target urate level of <6 mg/dl. 2nd line is probenacid, which can also be added if urate not at goal and at max dose allopurinol/febuxostat.
colchicine - brand, dosing, contraindications, warnings, ADRs, notes
colcrys. tx dose: 1.2 mg PO then 0.6 mg in 1 h (do not exceed 1.8 mg in 1 h). do not repeat dose before 3 d. contraindications: combo with pgp or strong 3a4 inhibitor when pt has renal/hep impairment. warnings: GI sx (dec dose if anorexia or diarrhea, V), myopathy risk. ADRs; NVD, myelosuppression, myopathy, neuropathy (dose related). start <36 h of onset of sx for tx. If taking ppx dose, wait 12 h after tx dose to resume ppx dose.
NSAIDs approved for gout + notes
indomethacin (indocin), naproxen (Naprosyn), sulindac (clinoril) BID, celecoxib (celebrex) BID. avoid in severe renal disease. CVD risk (highest with celebrex)
Steroids approved for gout, admin forms, dosing
prednisone/prednisolone, methylprednisolone, triamcinolone. PO/IM/IV/intra-articular or as adrenocorticotropic hormone. pred 0.5/mg/kg/d PO x5-10 d (no taper) OR 0.5 mg/kg/d x2-5 d then taper over 7-10 days.
allopurinol - brand, warnings, ADRs, notes, MOA
Zyloprim, +lesinurad is Duzallo. warnings: hypersens rxns including severe rash, HLA-B*5801 testing prior to use. ADRs: rash, acute gout attacks, ND (take after meal to reduce). higher doses used for tumor lysis syndrome. use with colchicine or NSAID for first 3-6 mo to ppx gout flares, xanthine oxidase inhibitor to dec uric acid production
febuxostat - brand, warnings, ADRs, notes, MOA
Uloric. warnings: hep tox. ADRs: rash, nausea, inc LFTs. has lactose. use with colchicine or NSAID for first 3-6 mo to ppx gout flares, xanthine oxidase inhibitor to dec uric acid production
lesinurad - brand, BBW, indicaiton, ADRs, MOI
Zurampic. BBW: acute renal failure esp if monotx, only use with XOI. ADRs: inc scr. indication: use with XOI if UA goals not reached with XOI alone. MOA: inhibit reabsorption of uric acid in kidneys, to inc uric acid excretion
probenecid - warnings, notes, MOA, indication
G6PD deficiency warning for hemolytic anemia. can be used to inc beta lactam levels by dec beta lactam renal excretion. MOA: inhibit reabsorption of uric acid in kidneys, to inc uric acid excretion. indication: 2nd line if contraindication to XOI or adjunct if not at goal with max XOI.
pegloticase - brand, form, BBW, contraindication, indication, warnings, MOA
krystexxa. IV only q2wks. BBW: anaphylactic rxns, premed with antiHAs and steroids, risk is higher if urate >6. contraindications: g6pd deficiency. warnings: acute gout flares, start NSAID or colchicine 1 wk prior to infusion and continue for at least 6 mo. do not use in combo with allopurinol or febuxostat, indication to replace, d/t inc risk of anaphylaxis. MOA: converts urate to allantoin (water solu metabolite) for excretion